| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP of Research &Development
1 company
Mann Brenda serves as a VP of Research &Development at KPRX. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $30K at current prices.
The biggest single holding is KPRX (~$30K) as VP of Research &Development. The recent filings there lean toward selling, a net 19,049 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2019 | KPRX Kiora Pharmaceuticals Inc | VP of Research &Development | Sell | 19,049 | $0.24 | $4,503.18 | -9.8% |